Successful emergency treatment with a transjugular intrahepatic portosystemic shunt for life-threatening Budd-Chiari syndrome with portal thrombotic obstruction

Hepato-Gastroenterology

Volumn 47, Issue 33, 2000, Pages 839-841

  Watanabe, Hisayoshi ^a   Shinzawa, Haruhide ^a   Saito, Takafumi ^a   Ishibashi, Masamichi ^a   Shirahata, Nakao ^a   Miyano, Shintaro ^a   Haga, Hiroko ^a   Aoki, Masanori ^a   Mitsuhashi, Hideki ^a   Matsuo, Taku ^a   Takashi, Abe ^a   Saito, Koji ^a   Yamada, Nobuo ^a   Togashi, Hitoshi ^a   Takahashi, Tsuneo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Budd Chiari syndrome; Polycythemia vera; Portal venous thrombosis; Tissue plasminogen activator; Transjugular intrahepatic portosystemic shunt

Indexed keywords

ALTEPLASE; DALTEPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

ADULT; ARTICLE; BUDD CHIARI SYNDROME; CASE REPORT; EMERGENCY SURGERY; FEMALE; HUMAN; POLYCYTHEMIA VERA; PORTAL VEIN BLOOD PRESSURE; PORTAL VEIN THROMBOSIS; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROGNOSIS; SHUNTING;

ADULT; FEMALE; HEPATIC VEIN THROMBOSIS; HUMANS; PLASMINOGEN ACTIVATORS; PORTAL VEIN; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR; VENOUS THROMBOSIS;

EID: 0034124446     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. 1 Anger BR, Seifried E, Scheppach J, Heimpel H: Budd-Chiari syndrome and thrombosis of other abdominal vassels in the chronic myeloproliferative diseases. Klin Wochenschr 1989; 67:818-825.
2. 2 DeStefano V, Teofili L, Leone G, Michiels JJ: Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997; 23:411-418.
3. 3 Ganguli SC, Ramzan NN, Mckusick MA, Andrews JC, Phyliky RL, Kamath PS: Budd-Chiari syndrome in patients with hematological disease: a therapeutic challenge. Hepatology 1998; 27:1157-1161.
4. 4 Nolte W, Figulla HR, Ringe B, WIltfang J, Mnüke H, Hartmann H, Ramadori G: Transjugular intrahepatic portosystemic stent shunt (TIPS) in Budd-Chiari syndrome with portal vein thrombosis. Dtsch Med Wschr 1997; 122:116-121.
5. 5 McMullin MF, Hillmen P, Jackson J, Ganly P, Luzzatto L: Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. J Intern Med 1994; 235:85-89.
6. 6 Frank JW, Kamath PS, Stanson AW: Budd-Chiari syndrome: early intervention with angioplasty and thrombolytic therapy. Mayo Clin Proc 1994; 69:877-881.
7. 7 Ochs A, Sellinger M, Haag K, Nöldge G, Herbst EW, Walter E, Gerok W, Rössle M: Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 1993; 18:217-225.
8. 8 Uhl MD, Roth DB, Riely CA: Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome. Dig Dis Sci 1996; 41:1494-1499.
9. 9 Rössle M, Siegerstetter V, Huber M, Ochs A: The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of art. Liver 1998; 18:73-89.
10. 10 Mahmoud AE, Helmy AS, Billingham L, Elias E: Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis. Eur J Gastroenterol Hepatol 1997; 9:485-489.